ArticleCell cycle (Georgetown, Tex.)2022

LOXL2 small molecule inhibitor restrains malignant transformation of cervical cancer cells by repressing

Ting Peng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.